Technology | Radiation Dose Management

The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer their artificial intelligence (AI)-powered region of interest (ROI) radiation exposure reduction solution FluoroShield for interventional X-ray imaging on their flat panel detector CS-series product lines.

Home April 04, 2019
Home
News | Advanced Visualization

Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are expected to drive growth of virtual reality (VR) in the healthcare market over the next several years, according to new research from Reports and Data. The report projects the market will reach a value of $6.91 billion by 2026. Advancements in the field of information technology (IT), including laptop, computer, internet connectivity and mobile applications will also be a significant factor stimulating market demand.

Home April 04, 2019
Home
News | Heart Valve Technology

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

Home April 03, 2019
Home
Technology | Stents

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

Home April 03, 2019
Home
Technology | Venous Therapies

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

Home April 03, 2019
Home
Technology | Vascular Closure Devices

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Technology

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

Home April 03, 2019
Home
News | Artificial Intelligence | Jeff Zagoudis, Associate Editor

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced Tuesday the agency is pursuing a new framework in which to review artificial intelligence (AI)-based medical software and devices to ensure ongoing effectiveness and patient safety. The agency released a 20-page discussion paper explaining the need for a new framework, the tenets of a total product lifecycle (TPLC) approach to certification, and examples of potential real-world AI software modifications that may or may not be permitted under the proposed framework. The FDA is asking for comments and feedback from all parties to inform future decisions.

Home April 02, 2019
Home
Technology | Virtual and Augmented Reality

Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform for anatomy education. Currently enabled on Microsoft's HoloLens AR technology and Magic Leap's spatial computing device, Magic Leap One, AnatomyX offers any member of a large university or medical institution an enterprise-grade learning platform for the study of human anatomy, physiology and pathology.

Home April 02, 2019
Home
News | Resuscitation Devices

April 2, 2019 — A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander cardiopulmonary ...

Home April 02, 2019
Home
How to reduce radiation dose in cardiac CT.
Feature | CT Angiography (CTA) | Dave Fornell, Editor

April 1, 2019 — Here is a checklist of dose-sparing practices for coronary computed tomography angiography (CCTA) ...

Home April 01, 2019
Home
The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.
Feature

April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home April 01, 2019
Home
News | Heart Failure

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, according to new research. The findings were presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans.

Home March 29, 2019
Home
News | Pacemakers

A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of patients with faulty cardiac rhythm devices in an emergency setting. The software has been able to identify the make and model of different devices, such as pacemakers and defibrillators, within seconds.

Home March 29, 2019
Home
News | Pharmaceuticals

Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy. These findings came from research presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans.

Home March 29, 2019
Home
Subscribe Now